Cabaletta Bio (CABA) Change in Accured Expenses (2018 - 2025)

Cabaletta Bio's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at $3.1 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses rose 631.88% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $7.4 million (up 88.29% YoY), while the FY2025 annual figure was $7.4 million, up 88.29% from the prior year.
• Change in Accured Expenses was $3.1 million for Q4 2025 at Cabaletta Bio, up from $2.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.4 million in Q3 2024 to a low of -$3.5 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $764200.0 across 5 years, with a median of $798500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 144.1% in 2022, then surged 878.15% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $1.7 million in 2021, then sank by 77.18% to $395000.0 in 2022, then soared by 674.94% to $3.1 million in 2023, then tumbled by 118.75% to -$574000.0 in 2024, then soared by 631.88% to $3.1 million in 2025.
• The last three Change in Accured Expenses figures came in at $3.1 million (Q4 2025), $2.3 million (Q3 2025), and $5.6 million (Q2 2025), per Business Quant data.